← Evidence map

ArticleFrontiers in immunology2025

Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma.

Liu-Xia Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40051634